Samuel Armato to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Samuel Armato has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.037
-
Optimization of response classification criteria for patients with malignant pleural mesothelioma, a validation study. Lung Cancer. 2019 12; 138:139-140.
Score: 0.037